Our Health Library information does not replace the advice of a doctor. Please be advised that this information is made available to assist our patients to learn more about their health. Our providers may not see and/or treat all topics found herein.

Eladocagene exuparvovec-tneq Injection

Brand Name(s): Kebildi®

WHY is this medicine prescribed?

Eladocagene exuparvovec-tneq is used to treat L-amino acid decarboxylase (AADC) deficiency (genetic disease that alters the production of signals that allow cells in the nervous system to communicate with each other). Eladocagene exuparvovec-tneq is in a class of medications called gene therapy. It works by improving production of signals needed for cells in the nervous system to communicate.

Are there OTHER USES for this medicine?

This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.

HOW should this medicine be used?

Eladocagene exuparvovec-tneq comes as a suspension (liquid) to be given intraputaminally (into a region of the brain) during a surgical procedure at a hospital that is able to perform these procedures. Your doctor will tell you what to expect before, during and after the procedure to receive eladocagene exuparvovec-tneq. The surgical procedure to give eladocagene exuparvovec-tneq may be associated with complications and so your doctor will monitor you closely in the hospital for a period of time.

Ask your pharmacist or doctor for a copy of the manufacturer's information for the patient.

What SPECIAL PRECAUTIONS should I follow?

Before receiving eladocagene exuparvovec-tneq,

  • tell your doctor and pharmacist if you are allergic to eladocagene exuparvovec-tneq, any other medications, or any of the ingredients in eladocagene exuparvovec-tneq injection. Ask your pharmacist for a list of the ingredients.

  • some medications should not be taken with eladocagene exuparvovec-tneq. Make sure you have discussed any medications you are currently taking or plan to take before starting eladocagene exuparvovec-tneq injection with your doctor and pharmacist. Before starting, stopping, or changing any medications while taking eladocagene exuparvovec-tneq injection, please get the advice of your doctor or pharmacist.

  • tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take.

  • tell your doctor if you are pregnant, plan to become pregnant, or are breast-feeding. Your doctor may have you take a pregnancy test prior to receiving eladocagene exuparvovec-tneq. If you become pregnant after receiving eladocagene exuparvovec-tneq, call your doctor.

What SPECIAL DIETARY instructions should I follow?

Unless your doctor tells you otherwise, continue your normal diet.

What SIDE EFFECTS can this medicine cause?

Eladacogene exuparvovac-tneq may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

  • fever
  • excess salivation
  • trouble falling or staying asleep
  • feeling dizzy or lightheaded
  • feeling tired, pale skin, shortness of breath, headache, cold hands or feet, brittle nails or hair loss
  • muscle weakness or cramping
  • muscle weakness, spasms or tremors; nausea, vomiting or loss of appetite; abnormal eye movements

Some side effects can be serious. If you experience any of these symptoms, call your doctor immediately:

  • involuntary movements of face, arm, leg or body such as fidgeting, writhing, wriggling, head bobbing or body swaying

Eladocagene exuparvovec-tneq may cause other side effects. Call your doctor if you have any unusual problems while taking this medication.

If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (https://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

What OTHER INFORMATION should I know?

Keep all appointments with your doctor and the laboratory. Your doctor may order certain lab tests to check your body's response to eladocagene exuparvovec-tneq.

Eladocagene exuparvovec-tneq is made from adeno-associated virus (small viruses that can infect humans). Vector shedding (release of parts of virus from the patient's body) can occur from 3 weeks after receiving eladocagene exuparvovec-tneq. Be sure to wash hands frequently and use gloves for dressing changes and handling of any waste material (e.g. blood, nasal secretions, urine, stool). Put any waste materials that have come into contact with body fluids in sealed bags before disposing of it. Do not donate blood, organs, tissues or cells for transplantation.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

Dear patient

I am excited to announce that I will be relocating my practice to Houston Methodist DeBakey Cardiology Associates. Starting November 4, 2024, my new address will be:

5115 Fannin, Suite 801
Houston, TX 77004

Please note that my phone number and fax number will also change to the following:
24-Hour Telephone: 713-441-1100
Fax: 713-790-2643
Clinical Support Telephone (M-F, 8-5): 713-441-3515

I am excited about caring for you in my new office and hope you will make the transition with me. I will also continue to refill your medications as I have in the past. To assist, please provide your pharmacy with my new contact information.

Please consider checking your prescription refills to verify that you have enough medication on hand to last you until your next visit. Please note that your medical records will remain at my former office until you authorize their transfer. If you choose for me to continue providing your medical care, please complete and sign the enclosed “Authorization for Release of Medical Records” form and fax it to 713-790-2643. Once we receive your authorization, we will be happy to process the request for you.

Thank you for entrusting me with your medical care. My new team and I are dedicated to making this transition as seamless as possible. For help scheduling an appointment and transitioning your care, please call my new office number above.

I look forward to continuing your care at my new location.

Sincerely,
Gopi A. Shah, MD

Dear patient

Dr. Albert Raizner, Dr. Michael Raizner, and Dr. Mohamed El-Beheary are excited to announce that our practice, Interventional Cardiology Associates, will merge with Houston Cardiovascular Associates on November 1, 2024.

Our new offices are similarly located in Houston, near the Texas Medical Center and in Sugar Land. Our in-hospital care will continue at Houston Methodist Hospital in the Texas Medical Center and Houston Methodist Sugar Land Hospital. Importantly, our new offices expand our services with state-of-the-art equipment and amenities. Our core values will always be, as they began over 40 years ago when Dr. Albert Raizner founded ICA:

Integrity – Compassion – Accountability

Our new address and contact information are:

Your medical records are confidential and remain available at our new locations. We consider it a privilege to serve as your cardiologists and look forward to your continuing with us. However, should you desire to transfer to another physician, you may request a copy of your records by contacting us at our new addresses and phone numbers listed above.

We thank you for your trust and loyalty. As always, we will continue to be here to take care of you. Please do not hesitate to contact us if you have any questions or concerns.

Sincerely,

Dr. Albert Raizner,
Dr. Michael Raizner,
Dr. Mohamed El-Beheary